Abstrak
Dengue virus infection can manifest as wide spectrum from asymptomatic, mild self-limiting febrile illness, dengue fever (DF) or severe dengue hemorrhagic fever (DHF). 1 The characteristic features of DHF are increasing of capillary permeability caused hemococentration, increased hematocrit and thrombocytopenia. Extensive plasma leakage into serous cavities of the body also caused hypotension, profound shock and death.
The pathogenesis of DHF is still not fully understood. Several clinical studies support the hypothesis that cytokine production is important in the pathogenesis of DHF.
2 Interleukin (IL)-18 originally described as IFN  inducing factor, a pro-inflammatory cytokine and an important stimulator or mediator of Th1 and Th2 immune response, enhances NK cell cytotoxicity. [3] [4] The main source of IL-18 is macrophage like cells. In the present study have investigated IL-18 protein expression in primary human macrophages in response to influenza A and Sendai virus infection. 5 Macrophages expressed pro IL-18 but produce biologically active IL-18 only after virus infection. The IL-18 release was due to virus infection induces proteolytic processing of 24 kDa pro IL-18 into its mature 18 kDa form. Pro IL-18 processing required active caspase-1 enzyme. 6 IL-18 collaboration with IL-12 to produce of IFN  from CD4 + Th1 cells, B cells and NK cells. 7 Unlike IL-12 which was high in DF and absent in patients with DHF especially grade III and IV; all of the Th 2 type cytokines are high in DHF/severe dengue infection. [8] [9] [10] A recent study has shown that IL-18 is a potent co inducer of IL-13 in NK cells and Th cells (Th 2 ). It can act as a strong co inducer of Th 1 or Th 2 cytokines. [11] [12] This could explain its role in dengue virus infection.
In this study we will investigate IL-18 levels in adult dengue fever and dengue hemorrhagic fever, and the correlation with severity and degree of hemoconcentration and thrombocytopenia.
METHODS
Study subject were enrolled from acute dengue cases, admitted in Dr. Cipto Mangunkusumo and Persahabatan general hospital during December 1999 until July 2000. Patients clinically presented as dengue fever or dengue hemorrhagic fever were enrolled to this study. Clinical data were recorded include age, sex, duration of fever, other symptoms and bleeding manifestations. The laboratory test were performed include serial hematocrit, platelets counts and dengue serology. The serum specimen were collected once daily, storage and freeze in -40 o C for IL-18 cytokine examination.
Depending on clinical manifestation, serial hematocrit levels, platelet counts, the presence of ascites or pleural effusion, the subjects were diagnosed as dengue fever, dengue hemorrhagic fever grades I, II, III and IV. Dengue fever determined if there is no evidence of plasma leakage. DHF if there are evidence of plasma leakage include the increasing of serial hematocrit levels more than 20% between the acute and convalescence phase, ascites or pleural effusion. DHF grade I, II, III and IV determined by the criteria of WHO. 
RESULTS
Forty-two subjects were enrolled to this study during the period (17 male and 25 female, median age 21 years old) ( Table 1 ). Duration of fever from the first day of fever to the day of admission between 2 to 6 days. Twenty cases (47.62 %) were defined as dengue fever and 22 cases (52.38 %) as dengue hemorrhagic fever. Most of DHF cases was grade I and II (18 of 22 cases) and dengue shock found in 3 subjects. Most of bleeding manifestation were positive tourniquet test and petechia; other istes include nose, vaginal, and GI tract. (Table 1 ). (Figure 2 ). Comparison between DHF grade I-II and III-IV showed insignificant differences (Mann-Withney test>0.05). Correlation between IL-18 levels, hematocrit and platelet count show significant correlation with r s = 0.313 and p=0.000 ( Figure 3) ; and r s =-0.222 p=0.004 (Figure 4) . Correlation between IL-18 levels, hematocrit and platelet count according to day of illness show in table 2. There are moderate to strong correlation between the IL-18 levels, hematocrit and count. 
DISCUSSION
Interleukin-18 is primary produced by monocyte / macrophages in response to dengue infection. 5 The results of this study demonstrate elevated levels of IL-18 in the patients with DF and DHF and correlated with hematocrit and platelet value. The levels of IL-18 were significantly higher in patients with DHF compare to DF. These findings suggest that IL-18 is produced in response to dengue virus infection and may have a important role against severe dengue disease.
Interleukin-18 is an important immune-regulatory cytokine and has been shown to enhance host cellular responses, including the ability to promote clearance of virus. 4 The studies on the dengue patients showed the shift from the predominant Th 1 type cytokine response observed in DF to Th 2 type response in patients with severe DHF. 2, 10 Based on these results, it has been proposed that dengue virus induces the production of a cytokine cascade that shifts from Th 1 dominant response to Th 2 response, resulting in severe DHF. The results of this study are consistent with the hypothesis that the presence of IL-18 is associated with Th 1 type response and Th 2 type response (levels of IL-18 in patients dengue correlated with the severity of the disease). These findings support the possible role of IL-18 in pathogenesis of dengue hemorrhagic fever.
CONCLUSIONS
Interleukin-18 levels increased both in DF and DHF patients, especially in the first 4 day of illness. Interleukin-18 levels significantly higer in DHF compare to DF patients and correlated with hematocit and platelet value.
